|
|
|
|
|
|
Sponsored by: |
Texas Tech University |
Information provided by: | Texas Tech University Health Sciences Center |
ClinicalTrials.gov Identifier: | NCT00233428 |
The purpose of this study is to see if there is a racial and/or gender difference in platelet aggregation.
Condition | Intervention | Phase |
Platelet Aggregation |
Procedure: Blood Draw |
Phase I |
Study Type: | Observational |
Study Design: | Screening, Cross-Sectional, Defined Population, Prospective Study |
Official Title: | Phase 1 Study to Determine Racial and Gender Differences in Platelet Aggregation |
Estimated Enrollment: | 60 |
Study Start Date: | May 2005 |
Estimated Study Completion Date: | May 2006 |
Genetic variability of various components of the coagulation system has been reported. Data on racial and gender differences in platelet aggregation are lacking.
We hypothesize that there are significant racial and gender differences on aggregatory response of platelets to commonly used agonists to evaluate platelet function such as adenosine diphosphate (ADP), epinephrine, collagen and arachidonic acid.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | L05-108 |
First Received: | October 3, 2005 |
Last Updated: | April 19, 2007 |
ClinicalTrials.gov Identifier: | NCT00233428 |
Health Authority: | United States: Institutional Review Board |
|
|